Designing a diagnostic kit for Oxalyl CoA Decarboxylase enzyme by ELISA method.


Journal

Immunology letters
ISSN: 1879-0542
Titre abrégé: Immunol Lett
Pays: Netherlands
ID NLM: 7910006

Informations de publication

Date de publication:
01 2019
Historique:
received: 13 09 2018
accepted: 09 11 2018
pubmed: 18 11 2018
medline: 21 12 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Urinary stones are the third most commonly reported urinary tract disease. Kidney stones are one of the most common types of urinary stones that most of them (70-80%) are calcium oxalate. Oxalic acid is highly oxidized organic compounds, which found in dietary and produced by the intestinal microflora. Oxalyl CoA decarboxylase is a key enzyme and plays an important role in oxalate degradation. In this study, the Oxalyl CoA decarboxylase gene which contains an -histidine tag was cloned in pET 28a (+) and expressed in Escherichia coli BL21 (DE3). The purified Oxalyl CoA decarboxylase protein was injected into rabbit for immunization. The antibody against Oxalyl CoA decarboxylase protein was used in ELISA assy. eventually, this ELISA system was used for patients with calcium oxalate kidney stones. ELISA analysis of serum samples of patient white calcium oxalate kidney stones showed that 88.8% of patient was lacking in antibody against Oxalyl CoA decarboxylase. This study suggests that antibodies against oxalyl-co-decoxylase proteins are useful in the detection of urinary tract stones and It can be used to measure oxalyl CoAdecoxylase enzymes in a simple method.

Identifiants

pubmed: 30447308
pii: S0165-2478(18)30403-6
doi: 10.1016/j.imlet.2018.11.008
pii:
doi:

Substances chimiques

Bacterial Proteins 0
Immunoglobulin G 0
Reagent Kits, Diagnostic 0
Recombinant Fusion Proteins 0
Calcium Oxalate 2612HC57YE
Carboxy-Lyases EC 4.1.1.-
oxalyl CoA decarboxylase EC 4.1.1.8

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

78-83

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Fatemeh Abarghooi-Kahaki (F)

Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Abbas Basiri (A)

Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: basiri@unrc.ir.

Mojgan Bandehpour (M)

Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Departments of Biotechnology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Bahram Kazemi (B)

Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Cellular and Molecular Biology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran; Departments of Biotechnology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: kazemi@sbmu.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH